[1] Fotbolcu H,Zorlu E. Nonalcoholic fatty liver disease as a multi-systemic disease. World J Gastroenterol,2016,22:4079.
[2] 徐毓,王来友,郭姣.代谢性核受体介导非酒精性脂肪性肝病的研究进展.广东药学院学报,2016,32:394-397. .
[3] 陈景娴,栾晓军,陈劲松.非酒精性脂肪肝与骨密度关联研究的相关进展. 中国骨质疏松杂志,2018,24:141-145.
[4] 李艳敏,刘章臣,史华民. 非酒精性肝病对绝经期妇女骨代谢生化指标的影响. 医学理论与实践,2017,30:2770-2771.
[5] 余利,冉莉,喻瑾,等. 非酒精性脂肪性肝病患者血清维生素与抗氧化指标检测分析.重庆医学,2018,47:347-1350.
[6] Amin S, Amrousy D El,Elrifaey S,et al. Serum osteocalcin levels in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr,2017,66:117-121.
[7] 娄爱菊,吴炜戎,蔡晓燕,等. 氧化应激和骨代谢水平与类风湿关节炎合并低骨量的相互关系. 中国骨质疏松杂志,2016,22:335-339.
[8] Yang H J,Shim S G,Ma B O,et al. Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men. Eur J Gastroenterol Hepatol,2016,28:338.
[9] 吴华贵,李远辉,向阳,等. 骨代谢生化指标PINP,CTX,NTX与抗氧化应激酶在预测绝经期后女性髋部骨折中的意义. 现代诊断与治疗,2017,28:1845-1847.
[10] 吴华贵.激素性股骨头坏死患者血清Ⅰ型前胶原氨基端前肽、Ⅰ型胶原C端肽、骨钙素的变化探讨.中国当代医药,2018,25:74-76.
[11] 田志,杨召旭,范静,等,老年骨折患者血清25OHD和PTH水平与骨质疏松程度的相关性.重庆医学,2018,47:767-769. |
